Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Eschscholzia californica extract** is an herbal preparation derived from the aerial parts (and sometimes roots) of the California poppy, a plant native to western North America. The extract contains a range of alkaloids, notably benzylisoquinoline alkaloids such as protopine, allocryptopine, californidine, and pavine, which are thought to modulate gamma-aminobutyric acid (GABA) receptors in the central nervous system. The extract is traditionally used as a dietary supplement for its **sedative, anxiolytic, mild analgesic, antispasmodic, and hypnotic** effects[1][2][3][4][5][6]. It is marketed primarily to promote sleep, reduce nervous tension, and ease anxiety or mild pain. Scientific evidence is limited but suggests possible sedative and anxiolytic effects, likely via GABAergic modulation. It is non-narcotic and considered gentle enough for children, but it may interact with some pharmaceuticals, particularly blood pressure drugs and anticoagulants[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on eschscholzia californica extract.